PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-3.99%
Negative revenue growth while 3141.T stands at 10.20%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-3.25%
Negative gross profit growth while 3141.T is at 17.55%. Joel Greenblatt would examine cost competitiveness or demand decline.
-19.17%
Negative EBIT growth while 3141.T is at 64.33%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-27.13%
Negative operating income growth while 3141.T is at 111.01%. Joel Greenblatt would press for urgent turnaround measures.
-25.66%
Negative net income growth while 3141.T stands at 70.34%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-25.65%
Negative EPS growth while 3141.T is at 70.23%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-25.65%
Negative diluted EPS growth while 3141.T is at 70.34%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.00%
Share reduction while 3141.T is at 0.05%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 3141.T is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
5.51%
OCF growth of 5.51% while 3141.T is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
5.51%
FCF growth of 5.51% while 3141.T is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
27.44%
10Y revenue/share CAGR under 50% of 3141.T's 166.08%. Michael Burry would suspect a lasting competitive disadvantage.
49.80%
5Y revenue/share CAGR at 50-75% of 3141.T's 69.39%. Martin Whitman would worry about a lagging mid-term growth trajectory.
23.09%
3Y revenue/share CAGR at 50-75% of 3141.T's 35.85%. Martin Whitman would question if the firm lags behind competitor innovations.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
13.42%
Below 50% of 3141.T's 246.84%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
53.29%
5Y net income/share CAGR at 50-75% of 3141.T's 100.58%. Martin Whitman might see a shortfall in operational efficiency or brand power.
29.45%
Below 50% of 3141.T's 67.66%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
143.96%
10Y equity/share CAGR at 50-75% of 3141.T's 272.16%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
100.32%
5Y equity/share CAGR 1.25-1.5x 3141.T's 75.28%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
49.44%
3Y equity/share CAGR 1.25-1.5x 3141.T's 41.85%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
112.50%
Below 50% of 3141.T's 540.00%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
88.89%
5Y dividend/share CAGR at 75-90% of 3141.T's 100.00%. Bill Ackman wants more robust earnings or a higher payout ratio to match the competitor.
70.00%
3Y dividend/share CAGR above 1.5x 3141.T's 39.13%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
29.48%
AR growth well above 3141.T's 13.66%. Michael Burry fears inflated revenue or higher default risk in the near future.
10.13%
Inventory growth well above 3141.T's 0.43%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
1.50%
Asset growth well under 50% of 3141.T's 8.29%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
2.47%
Under 50% of 3141.T's 5.50%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-8.57%
We’re deleveraging while 3141.T stands at 17.06%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
3.12%
SG&A declining or stable vs. 3141.T's 6.94%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.